The discovery of an antiviral vaginal gel that can reduce HIV infection by around 50 per cent is good news, however qualified. More research is needed: the current clinical trial, in Durban, tested just 889 women. But the virtue of the gel is that it gives some autonomy to women, reducing their chance of contracting the virus when male partners refuse to use a condom. In South Africa, a third of all women between 20 and 34 are thought to be HIV-positive, and they account for some 60 per cent of new infections.
New protection from HIV?
On Thursday night I arrived in Cape Town and headed straight for Green Point Stadium to...